Sunshine Biopharma Inc. short interest in 2025
In 2025, Sunshine Biopharma Inc.'s disclosed short interest ran from 5.66% of shares outstanding on 14 Mar 2025 to 6.81% on 31 Dec 2025, a change of +1.15 percentage points. The year's high was 12.02% on 14 Nov 2025 and its low 3.31% on 30 Jun 2025, averaging 6.39% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.23 days on 15 Dec 2025. Full history: Sunshine Biopharma Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.66% (14 Mar 2025)
- End of year
- 6.81% (31 Dec 2025)
- Change
- +1.15 pp
- High
- 12.02% (14 Nov 2025)
- Low
- 3.31% (30 Jun 2025)
- Average
- 6.39%
- Highest days to cover
- 9.23 (15 Dec 2025)
- SEC filings marked
- 6
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Mar 2025 | 5.66% | 3.05 | |
| 31 Mar 2025 | 5.22% | 5.65 | |
| 15 Apr 2025 | 4.51% | 1.00 | 10-K filed, results (8-K) |
| 15 May 2025 | 9.57% | 1.97 | 10-Q filed |
| 30 May 2025 | 5.68% | 1.55 | results (8-K) |
| 13 Jun 2025 | 3.51% | 1.00 | |
| 30 Jun 2025 | 3.31% | 1.34 | |
| 15 Aug 2025 | 6.33% | 6.11 | 10-Q filed |
| 29 Aug 2025 | 5.44% | 5.95 | |
| 15 Sep 2025 | 4.80% | 4.68 | |
| 30 Sep 2025 | 4.58% | 3.48 | |
| 15 Oct 2025 | 8.01% | 1.72 | |
| 14 Nov 2025 | 12.02% | 5.74 | 10-Q filed |
| 28 Nov 2025 | 8.77% | 4.31 | |
| 15 Dec 2025 | 8.02% | 9.23 | |
| 31 Dec 2025 | 6.81% | 5.28 |
See also: Sunshine Biopharma Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.